These results have broader implications for the use of PPARG-targeting agents in obesity and metabolic disease research and provide a foundation for future studies investigating the molecular interplay between differentiation, metabolism, and cell death, potentially informing the development of novel therapeutic approaches. Here, PPARG is linked to Other metabolic disease.